Company intelligence / Profile preview

Taiwania Capital

Taipei City, Taipei, Taiwantaiwaniacapital.com ↗

Ownership: Private
Development stage: Other

Overview

Taiwania Capital is a leading venture capital firm based in Taiwan that invests globally across technology and life sciences. It manages multiple funds focused on biotechnology, pharmaceuticals, medtech devices (including AI-driven diagnostics), and healthcare technologies. The firm has backed numerous innovative startups developing new medicines for cancer and rare diseases as well as digital health solutions.

Modalities: Gene therapyCell therapyAI-driven medical deviceFirst-in-class therapeutic
Industry: Investors

Partnerships

Axil Capital Group (“TaiAx Life Science Fund” joint venture)

Beyond the preview

Go deeper on Taiwania Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taiwania Capital.

Explore the full profile